Proteomics

Dataset Information

0

Locally Advanced Rectal Cancer - Radiation Response Prediction Study - Serum Proteins


ABSTRACT: The study objective was to find new biomarkers of treatment response and adverse events in patients receiving neoadjuvant therapy for locally advanced rectal cancer. Patients received neoadjuvant chemotherapy (NACT) followed by chemoradiotherapy (CRT) and underwent treatment evaluation four weeks after CRT completion. Radical pelvic surgery was planned 2-4 weeks later. Patients were scored for treatment adverse events, according to Common Terminology Criteria for Adverse Events (CTCAE) version 3.0, throughout the neoadjuvant treatment course, including at NACT and CRT completion. Treatment response was assessed by histologic ypTN staging and tumor regression grade (TRG) scoring, as well as progression-free survival (time from Inclusion date to Date of local relapse or Date of metastatic disease, whichever came first) recorded for five years after surgery.

ORGANISM(S): Homo sapiens

PROVIDER: GSE65622 | GEO | 2016/04/21

SECONDARY ACCESSION(S): PRJNA274494

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2022-01-27 | GSE181597 | GEO
2020-02-22 | GSE145666 | GEO
2014-08-01 | E-GEOD-45670 | biostudies-arrayexpress
2015-07-27 | E-GEOD-59974 | biostudies-arrayexpress
2023-03-11 | PXD037356 | Pride
2022-10-05 | PXD031929 | Pride
2022-12-31 | GSE193707 | GEO
2022-12-31 | GSE193719 | GEO
2020-12-11 | GSE163002 | GEO
2023-01-12 | GSE216333 | GEO